Page 23 - FPGEE Medicinal and Organic Chemistry Q&A Book
P. 23

Krisman



               ulbar neuritis, occurring in association with     256. (c) Dapsone or 4,4’-diaminodiphenylsulfone
               ethambutol therapy may be characterized by one    or 4,4’-Sufonyldianiline is an pharmacological
               or more of the following events: decreased        medication most commonly used in combination
                                                                 with  rifampicin  and  clofazimine  as  multidrug
               visual acuity, scotoma, color blindness, and/or
                                                                 therapy (MDT) for the treatment of Mycobacterium
               visual defect. These events have also been re-
                                                                 leprae infections (leprosy).
               ported in the absence of a diagnosis of optic or
               retrobulbar neuritis. Patients should be advised
                                                                                     O
               to report promptly to their physician any change
               of visual acuity.                                   NH 2              S                NH 2
                                                                                     O
               253. (c) The compound shown in the structure
                                                                          4,4'-Diaminodiphenylsulfone
               is ethionamide (Trecator). The IUPAC name for
                                                                                 (Dapsone)
               this  compound  is  2-ethylpyridine-4-
               carbothioamide.  It  is  antibacterial  agent
                                                                 257. (b) Cisplatin (Platinol) is organometallic
               indicated for the treatment of tuberculosis.
                                                                 neoplastic agent. It is used for the treatment of
                                                                 metastatic testicular, ovarian and advanced
               254. (c) Para-aminosalicylic acid is used as sec-
                                                                 bladder cancer. Severe nausea and vomiting are
               ond-line agent for the treatment of tuberculo-
                                                                 reported with Cisplatin.  Use of antiemetic agent
               sis. It is thought to act as an antimetabolite in-
                                                                 is  required  prior  to  cisplatin    therapy.
               terfering with the incorporation of p-aminoben-
                                                                 Myelosuppression and ototoxicity, including ir-
               zoic acid into folic acid. When coadministered
                                                                 reversible hearing loss, is also reported with the
               with INH (Isoniazid), para-aminosalicylic acid
                                                                 therapy.
               (PAS) is found to reduce the acetylation of INH,
               itself being the substrate for acetylation, thus
                                                                 258. (d) Cis-diamminedichloridoplatinum or
               increasing the plasma level of INH.
                                                                 Cisplatin or Platinol is highly nephrotoxic in
                                                                 nature. It should be carefully prescribed with
               255. (c) Phenazine, also called dibenzopyrazine,
                                                                 other  nephrotoxic  agents  such  as
               is a dibenzo annulated pyrazine and the parent
                                                                 cyclophosphamide, ifosfamide and streptomy-
               substance  of  many  dyestuffs,  such  as  the
                                                                 cin.
               eurhodines, toluylene red, indulines and safra-
               nines.  Being a phenazine derivative water-
                                                                 259. (b)  To protect patients against cisplatin-
               insoluble dark-red dye, it leads to pigmentation
                                                                 induced nephrotoxicity, patients should be hy-
               of the skin and discoloration of tears, sweat,
                                                                 drated with chloride containing solution prior
               sputum and urine.
                                                                 to therapy. Use of saline or mannitol diuretics
                                    N                            is also recommended to promote continuous
                                                                 excretion of the drug and its water soluble
                                                                 metabolite. Cisplatin is very strongly bound to
                                    N
                                                                 plasma protein, and therefore dialysis cannot
                          phenazine or  dibenzopyrazine
                                                                 rescue patients from cisplatin induced toxicity.
               Clofazimine (Lamprene)  is  used in combina-
                                                                 260. (c) Sodium thiosulfate is used to minimize
               tion with rifampicin and dapsone as multidrug
                                                                 cisplatin -induced bladder and kidney toxicity.
               therapy (MDT) for the treatment of leprosy.
                                                                 The drug accumulates in renal tubules where it
                                                                 neutralizes active drugs in the kidney. The serum




               www.pharmacyexam.com                                                                   147
   18   19   20   21   22   23   24   25   26   27   28